The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections are increasingly available ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many ...

Deputy President welcomes rollout of HIV prevention injection Deputy President Paul Mashatile has hailed South Africa’s upcoming rollout of Lenacapavir as a potential game-changer in the country’s ...

According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

How Does Yeztugo Work to Prevent HIV? HIV is a virus that has a coating around it, which is called a capsid. In order for HIV to make copies of itself and spread within your body, it needs to get ...

Globally, more than one million children who are HIV-exposed but uninfected (CHEU) are born every year. Numerous studies have documented that CHEU are at ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

The Federal Government has confirmed the arrival of the long-acting HIV prevention injection, Lenacapavir, marking a major ...

A major challenge in connecting people living with HIV to proper care is a changing workforce, say the researchers. The number of HIV specialists is declining, despite a growing patient population ...